As advised via PHARMAC Tender Results of 29 March 2019 there is to be a change in the listing and future sole supply of Furosemide Tablets 40mg.

New listing from 1 October 2019

Frusemide-Apo Tablets 40mg 1000                                                            Pharmacode TBA                                Schedule price $7.24

Incumbent brand

Diurin Tab 40 mg 1000 Mylan                                                                      Pharmacode 282014                                        Schedule price $8.00

Reference pricing will apply from 1 December 2019.

HSS (Hospital Supply Status) commences 1 December 2019.

CSS (Community Supply Status) commences 1 March 2020.

No Brand Switch Fee advised.

As of the date of this notification ProPharma / PWR cannot accept Diurin Tab 40 mg 1000 for credit under any circumstances.

From  1 October 2019 community pharmacies dispensing Furosemide Tablets 40 mg will need to support patients changing to the new brand and manage stock during the transition.

We would recommend you continue to purchase the incumbent and we will change automatically as existing stocks are exhausted.

You MUST manage your stock to avoid being caught with stock at the time reference pricing is applied 1 December 2019. Failure to do so could prove very costly.

Once again we need your support to ensure stock in the supply chain moves through, to effectively ensure no losses are incurred by either party.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author